DOCSLIB.ORG

Protect Commercial AGREEMENT Between Buying Solutions and XMA

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Protect Commercial AGREEMENT Between Buying Solutions and XMA RESTRICTED - COMMERCIAL Government Office Supplies Contract Contract Protect Commercial AGREEMENT between Buying Solutions and XMA Limited for the provision of Office Supplies (Product Grouping 2) Version: 1 Contract Ref: RM917B Start Date: 1 August 2011 Expiry Date: 31 July 2013 RESTRICTED - COMMERCIAL Page 1 of 49 RESTRICTED - COMMERCIAL Government Office Supplies Contract Contract CONTENTS FORM OF AGREEMENT ...................................................................................................... 5 TERMS AND CONDITIONS ................................................................................................. 6 A GENERAL PROVISIONS .......................................................................................... 6 A1 Definitions and Interpretation ............................................................................ 6 A2 Initial Contract Period ..................................................................................... 13 A3 Scope of Contract ........................................................................................... 13 A4 Non-exclusivity ............................................................................................... 14 A5 Contractor’s Status ......................................................................................... 15 A6 Contracting Authority’s Obligations ................................................................. 15 A7 Notices….. ...................................................................................................... 15 A8 Mistakes in Information ................................................................................... 16 A9 Conflicts of Interest ......................................................................................... 16 A10 Access to Customer’s Premises ..................................................................... 16 A11 Staff Vetting .................................................................................................... 17 A12 Security of Premises ....................................................................................... 17 A13 Security Requirements ................................................................................... 18 A14 Property… ...................................................................................................... 18 A15 Guarantee ...................................................................................................... 19 B PAYMENT TERMS AND CHARGES ...................................................................... 19 B1 Charges. ........................................................................................................ .19 B2 Payment Terms and VAT ............................................................................... 19 B3 Recovery of Sums Due ................................................................................... 20 B4 Compliance with Value Added Tax and Other Tax Requirements ................... 21 B5 Arrears of Value Added Tax ........................................................................... 21 B6 Price adjustment on extension of the Initial Contract Period ........................... 21 B7 Euro……….. ................................................................................................... 21 C STATUTORY OBLIGATIONS AND REGULATIONS .............................................. 21 C1 Prevention of Corruption ................................................................................. 21 C2 Prevention of Fraud ........................................................................................ 22 C3 Discrimination ................................................................................................. 22 C4 The Contracts (Rights of Third Parties) Act 1999 ............................................ 23 C5 Health and Safety ........................................................................................... 23 D DATA SECURITY AND PROTECTION OF INFORMATION ................................... 23 RESTRICTED - COMMERCIAL Page 2 of 49 RESTRICTED - COMMERCIAL Government Office Supplies Contract Contract D1 Customer Data ............................................................................................... 23 D2 Data Protection Act ......................................................................................... 23 D3 Official Secrets Acts and related Legislation ................................................... 25 D4 Confidential Information .................................................................................. 25 D5 Freedom of Information .................................................................................. 26 D6 Transparency ................................................................................................. 27 D7 Publicity, Media and Official Enquiries ............................................................ 28 D8 Intellectual Property Rights ............................................................................. 28 E CONTROL OF THE CONTRACT ............................................................................ 30 E1 Transfer, Sub-Contracting and Novation ......................................................... 30 E2 Waiver…......................................................................................................... 31 E3 Variation … ..................................................................................................... 31 E4 Severability ..................................................................................................... 32 E5 Remedies Cumulative .................................................................................... 32 E6 Extension of Initial Contract Period ................................................................. 32 E7 Entire Agreement ............................................................................................ 32 F LIABILITIES ............................................................................................................ 32 F1 Liability, Indemnity and Insurance ................................................................... 32 F2 Warranties and Representations .................................................................... 34 F3 Professional Indemnity ................................................................................... 35 G DEFAULT, DISRUPTION AND TERMINATION ...................................................... 35 G1 Termination on insolvency and change of control ........................................... 35 G2 Termination on Default ................................................................................... 37 G3 Break…………. ............................................................................................... 38 G4 Consequences of Expiry or Termination ......................................................... 38 G5 Disruption ....................................................................................................... 39 G6 Recovery upon Termination ............................................................................ 39 H DISPUTES AND LAW ............................................................................................. 40 H1 Governing Law and Jurisdiction ...................................................................... 40 H2 Dispute Resolution ......................................................................................... 40 H 3 Legislative Change ......................................................................................... 41 I (NOT USED)............................................................................................................ 42 J SUPPLY OF GOODS .............................................................................................. 42 J1 The Goods……............................................................................................... 42 J2 Contract Performance .................................................................................... 42 RESTRICTED - COMMERCIAL Page 3 of 49 RESTRICTED - COMMERCIAL Government Office Supplies Contract Contract J3 Delivery…........ ............................................................................................... 43 J4 Ownership and Risk ....................................................................................... 43 J5 Non-Delivery……. ........................................................................................... 43 J6 Inspection, Rejection and Guarantee .............................................................. 44 K ORDERING PROCEDURE ...................................................................................... 44 L MANAGEMENT INFORMATION ............................................................................. 45 L1 Provision of Management Information ............................................................ 45 L2 Management Charge ...................................................................................... 45 L3 Records and Audit Access .............................................................................. 45 M FURTHER EFFICIENCIES, INCENTIVISATION, AND GAINSHARE ..................... 47 N ASSISTANCE IN RELATED PROCUREMENTS AND ETHICAL WALL ARRANGEMENTS .................................................................................................. 47 O FURTHER ASSURANCES ..................................................................................... 48 RESTRICTED - COMMERCIAL Page 4
Load more

Recommended publications
  • Deficiency of the Zinc Finger Protein ZFP106 Causes Motor and Sensory
    Human Molecular Genetics, 2016, Vol. 25, No. 2 291–307 doi: 10.1093/hmg/ddv471 Advance Access Publication Date: 24 November 2015 Original Article ORIGINAL ARTICLE Deficiency of the zinc finger protein ZFP106 causes Downloaded from https://academic.oup.com/hmg/article/25/2/291/2384594 by guest on 23 September 2021 motor and sensory neurodegeneration Peter I. Joyce1, Pietro Fratta2,†, Allison S. Landman1,†, Philip Mcgoldrick2,†, Henning Wackerhage3, Michael Groves2, Bharani Shiva Busam3, Jorge Galino4, Silvia Corrochano1, Olga A. Beskina2, Christopher Esapa1, Edward Ryder4, Sarah Carter1, Michelle Stewart1, Gemma Codner1, Helen Hilton1, Lydia Teboul1, Jennifer Tucker1, Arimantas Lionikas3, Jeanne Estabel5, Ramiro Ramirez-Solis5, Jacqueline K. White5, Sebastian Brandner2, Vincent Plagnol6, David L. H. Bennet4,AndreyY.Abramov2,LindaGreensmith2,*, Elizabeth M. C. Fisher2,* and Abraham Acevedo-Arozena1,* 1MRC Mammalian Genetics Unit, Harwell, Oxfordshire OX11 0RD, UK, 2UCL Institute of Neurology and MRC Centre for Neuromuscular Disease, Queen Square, London WC1N 3BG, UK, 3Health Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK, 4Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK, 5Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK and 6UCL Genetics Institute, London WC1E 6BT, UK *To whom correspondence should be addressed. Email: [email protected] (A.A.)/e.fi[email protected] (E.M.C.F.)/[email protected] (L.G.) Abstract Zinc finger motifs are distributed amongst many eukaryotic protein families, directing nucleic acid–protein and protein–protein interactions. Zinc finger protein 106 (ZFP106) has previously been associated with roles in immune response, muscle differentiation, testes development and DNA damage, although little is known about its specific function.
    [Show full text]
  • Abstracts of Papers Presented at the Tenth Mammalian Genetics And
    Genet. Res., Camb. (2000), 76, pp. 199–214. Printed in the United Kingdom # 2000 Cambridge University Press 199 Abstracts of papers presented at the tenth Mammalian Genetics and Deelopment Workshop (Incorporating the Promega Young Geneticists’ Meeting) held at the Institute of Child Health, Uniersity College London on 17–19Noember 1999 " # Edited by: ANDREW J. COPP AND ELIZABETH M. C. FISHER 1Institute of Child Health, Uniersity College London, 30 Guilford Street, London WC1N 1EH, UK # Neurogenetics Unit, Imperial College School of Medicine, St Mary’s Hospital, Norfolk Place, London W2 1PG, UK Sponsored by: The Genetical Society, Promega (UK) Ltd and B&K Universal Group Ltd Evidence for imprinting in type 2 diabetes: detection of Identification of a locus for primary ciliary dyskinesia parent-of-origin effects at the insulin gene on chromosome 19 " " " STEWART HUXTABLE, PHILIP SAKER, LEMA S. L. SPIDEN , M. MEEKS , A. J. WALNE ,H. # # HADDAD, ANDREW HATTERSLEY, MARK BLAU , H. MUSSAFFI-GEORGY ,H. $ % % WALKER and MARK McCARTHY SIMPSON , M. EL FEHAID , M. CHEEBAB ,M. % % Section of Endocrinology, Imperial College School of AL-DABBAGH , H. D. HAMMUM ,R.M. " " Medicine, St Mary’s Hospital, London, UK GARDINER , E. M. K. CHUNG and H. M. " MITCHISON " Variation at the insulin gene (INS) VNTR is impli- Department of Paediatrics, Royal Free and Uniersity cated in type 1 diabetes, polycystic ovarian syndrome College Medical School, Uniersity College London, # and birthweight. Case-control studies inconsistently UK; Schneider Children’s Medical Center of Israel, $ show class III VNTR association with type 2 diabetes, Petech Tika, Israel; School of Medical Sciences, but may result from population stratification.
    [Show full text]
  • Sepnetplacements201314213.Pdf
    SEPnet Summer Placement Opportunities 2013 1 Dear SEPnet Student I am delighted to be able to present the opportunities available for SEPnet funded work placements in 2013. There are 35 industry placements and 12 research placements in total. Please read through the list of projects carefully – they offer a great opportunity for you to gain valuable work experience this summer. Details about the scheme are set out in the FAQs section below. Please make a note of the deadline dates, in particular, the application deadline of FRIDAY 29 MARCH. If you have any questions you can contact me on my email address below. I wish you all the best with your applications! Veronica Veronica Benson Keep up-to-date with SEPnet Director of Employer Liaison www.facebook.com/SEPnet South-East Physics Network Twitter @SEPhysics [email protected] www.sepnet.ac.uk FAQs How much will I get paid? Successful candidates will receive a bursary of £1,360 which is for eight weeks work in the summer holidays. How does the scheme work? 1. You need to register your details before you start applying. Go to the following page on our website and click on the link called Student Registration Form at: http://www.sepnet.ac.uk/employer_services/summer_internships/information_students.html NB: You will not be able to take up a placement if you have not registered here first. 2. Read the project descriptions in this booklet carefully. We recommend you apply for more than one placement and you may wish to apply for several but remember to target your applications to the projects that really interest you and check the location of the placement to make sure you can get there! 3.
    [Show full text]
  • The Social Structure, Ecology and Pathogens of Bats in the UK
    The Social Structure, Ecology and Pathogens of Bats in the UK Submitted by Thomas Adam August to the University of Exeter as a thesis for the degree of Doctor of Philosophy in Biological Sciences In September 2012 This thesis is available for library use on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement. I certify that all material in this thesis which is not my own work has been identified and that no material has previously been submitted and approved for the award of a degree by this or any other university. Signature: ………………………………………………………….. 1 2 Dedicated to the memory of Charles William Stewart Hartley 3 4 Abstract This thesis examines the ecology, parasites and pathogens of three insectivorous bat species in Wytham Woods, Oxfordshire; Myotis nattereri (Natterer’s bat), M. daubentonii (Daubenton’s bat) and Plecotus auritus (Brown long-eared bat). The population structure was assessed by monitoring associations between ringed individuals, utilising recent advances in social network analysis. Populations of both M. daubentonii and M. nattereri were found to subdivide into tight-knit social groups roosting within small areas of a continuous woodland (average minimum roost home range of 0.23km2 and 0.17km2 respectively). If this population structure is a general attribute of these species it may make them more sensitive to small scale habitat change than previously thought and has implications for how diseases may spread through the population. M. daubentonii had a strong preference for roosts close to water, away from woodland edge and in areas with an easterly aspect.
    [Show full text]
  • Download Original Attachment
    Doctor of Philosophy Charles Nyaigoti Agoti For a thesis entitled Genetic Diversity of Respiratory Syncytial Virus Strains in Relation to Infection and Re-Infection Sponsoring Establishment KEMRI - Wellcome Trust Research Programme, Kenya Pierre Akiki For a thesis entitled Engineering Adaptive User Interfaces for Enterprise Applications Amelina Andrea Albornoz For a thesis entitled The Role of TIA-1 as a Cellular Restriction Factor for Tick-Borne Encephalitis Virus Infection Sponsoring Establishment International Centre for Genetic Engineering and Biotechnology Margaret Elizabeth Andrews For a thesis entitled Lateritic Palaeosols of N E Africa: A Remote Sensing Study Vassileios Angelis For a thesis entitled Testing and Analysis of a Computational Model of Human Rhythm Perception Helen Arfvidsson For a thesis entitled On Burning Cars, Concrete and Citizenship Philip Ashton For a thesis entitled A Genomic and Proteomic Approach to Investigate the Clostridium botulinum Toxin Complex Sponsoring Establishment Professional Development Foundation Sophie Bailes For a thesis entitled Retention Mechanism for the Reversed Phase and Hydrophilic Interaction Liquid Chromatography Sophie Philippa Bankes For a thesis entitled James Lackington (1746-1815) and Reading in the Late Eighteenth Century Imran Bashir For a thesis entitled Acoustical Exploitation of Rough, Mixed Impedance and Porous Surface Outdoors Swaraj Basu For a thesis entitled Conservation and Synteny of Long Non-Coding RNAs in Vertebrate Genomes and their Identification in Novel Transcriptomes
    [Show full text]
  • Deficient Pancreatic Islets
    Physiological Reports ISSN 2051-817X ORIGINAL RESEARCH RNA-sequencing of WFS1-deficient pancreatic islets Marilin Ivask1, Alison Hugill2 & Sulev Koks~ 1 1 Department of Pathophysiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia 2 Mammalian Genetics Unit, Medical Research Council, Harwell, Oxfordshire, United Kingdom Keywords Abstract Insulin, RNA-sequencing, Trpm5, Wfs1. Wolfram syndrome, an autosomal recessive disorder characterized by juvenile- Correspondence onset diabetes mellitus and optic atrophy, is caused by mutations in the WFS1 Marilin Ivask, Department of gene. WFS1 encodes an endoplasmic reticulum resident transmembrane pro- Pathophysiology, Institute of Biomedicine and tein. The Wfs1-null mice exhibit progressive insulin deficiency and diabetes. Translational Medicine, University of Tartu, The aim of this study was to describe the insulin secretion and transcriptome 19 Ravila Street, 50411 Tartu, Estonia. of pancreatic islets in WFS1-deficient mice. WFS1-deficient (Wfs1KO) mice Tel: 372 737 4374 Fax: 372 7 374372 had considerably less pancreatic islets than heterozygous (Wfs1HZ) or wild- E-mail: [email protected] type (WT) mice. Wfs1KO pancreatic islets secreted less insulin after incuba- tion in 2 and 10 mmol/L glucose and with tolbutamide solution compared to Funding Information WT and Wfs1HZ islets, but not after stimulation with 20 mmol/L glucose. This study was supported by the European Differences in proinsulin amount were not statistically significant although Science Foundation grant SV/3452 within the there was a trend that Wfs1KO had an increased level of proinsulin. After framework of “Frontiers of Functional incubation in 2 mmol/L glucose solution the proinsulin/insulin ratio in Genomics”, by Estonian Science Foundation grant 7479, by institutional research funding Wfs1KO was significantly higher than that of WT and Wfs1HZ.
    [Show full text]
  • Abstracts of Papers Presented at the Twelfth Genetical Society's
    Genet. Res., Camb. (2002), 80, pp. 63–75. # 2002 Cambridge University Press 63 DOI: 10.1017\S0016672302005736 Printed in the United Kingdom Abstracts of papers presented at the twelfth Genetical Society’s Mammalian Genetics and Deelopment Workshop held at the Institute of Child Health, Uniersity College London on 5–7 December 2001 " # Edited by: ANDREW J. COPP ELIZABETH M. C. FISHER 1 Institute of Child Health, Uniersity College London, 30 Guilford Street, London WC1N 1EH, UK 2 Institute of Neurology, Uniersity College London, Queen Square, London WC1N 3BG, UK Sponsored by: The Genetics Society, Promega (UK) Ltd and B&K Universal Group Ltd of vascular endothelial growth factor (VEGF) Structural-Proliferative Units and Igf2 demonstrates that the balanced expression of VEGF isoforms regulates the choice between the alternate BILL BENNETT, ANDREW WARD and fates of growth in microvessel diameter versus growth JONATHAN SLACK in branching complexity. Microvessel networks of Deelopmental Biology Programme, School of Biology mouse embryos expressing only the VEGF120 isoform & Biochemistry, Uniersity of Bath, Bath, UK consisted of larger vessels with fewer branchpoints when compared with wild-type littermates. At the We know a great deal about molecular pathways cellular level, branching mutants largely lacked involved in the growth and proliferation of individual filopodia, which in wild-type littermates formed at the cells, but much less about how entire organs actually front of growing vessels and extended towards the grow, and almost nothing about how they know when VEGF source. Since VEGF isoforms differ in their to stop growing. Insulin-like growth factor II (Igf2) is ability to bind heparan sulphate proteoglycans in the a potent molecule.
    [Show full text]
  • Asante Et Al Dynein-2 Final Author Version
    Asante, D. , Stevenson, N. L., & Stephens, D. J. (2014). Subunit composition of the human cytoplasmic dynein-2 complex. Journal of Cell Science, 127(21), 4774-4787. https://doi.org/10.1242/jcs.159038 Peer reviewed version Link to published version (if available): 10.1242/jcs.159038 Link to publication record in Explore Bristol Research PDF-document University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/ SUBUNIT COMPOSITION OF THE HUMAN CYTOPLASMIC DYNEIN-2 COMPLEX. 1,2 1 DAVID ASANTE , NICOLA L. STEVENSON , AND DAVID J. STEPHENS* CELL BIOLOGY LABORATORIES, SCHOOL OF BIOCHEMISTRY, MEDICAL SCIENCES BUILDING, UNIVERSITY OF BRISTOL, BS8 1TD TEL: 00 44 117 331 2173 *CORRESPONDING AUTHOR. EMAIL: [email protected] 1 2 1 These authors contributed equally to this work. 2 PRESENT ADDRESS: MAMMALIAN GENETICS UNIT, MRC HARWELL, HARWELL SCIENCE AND INNOVATION CAMPUS, OXFORDSHIRE OX11 0RD, UK. KEYWORDS: MICROTUBULE MOTOR, DYNEIN, CILIA, INTRAFLAGELLAR TRANSPORT. 3 4 Number of words (not including references): 7608 5 SUMMARY 6 Cytoplasmic dynein-2 is the motor for retrograde intraflagellar transport and mutations in dynein-2 are known to cause 7 skeletal ciliopathies. Here we define for the first time the composition of the human cytoplasmic dynein-2 complex. We 8 show that the ciliopathy genes WDR34 and WDR60 are bona fide dynein-2 intermediate chains and are both required 9 for dynein-2 function.
    [Show full text]
  • IMPC Production, Phenotyping, Engagement
    UK Medical Research Council IMPC Production, Phenotyping, Engagement Tom Weaver Director, Mary Lyon Centre, MRC Harwell International Mouse Phenotyping Consortium Launch! 28/29th September 2011 NIH, Washington DC, USA An International Centre for Mouse Genetics Mary Lyon Centre Overview MRC Harwell & the MRC IMPC Engagement with Community Operations – Management & Immediate Plans Future Developments (if have time) An International Centre for Mouse Genetics Mary Lyon Centre UK Medical Research Council Established in 1911 Mission: Improve human health through world-class medical research $1B Budget (1/30th size of NIH) Over 4,000 people in 50 Institutes, Units and Centres Rich Scientific History 29 Nobel Laureates => DNA Structure, Targeted Mutagenesis in Mice Commitment to Basic & Translational Research An International Centre for Mouse Genetics Mary Lyon Centre MRC Strategic Plan 2009-2014: MRC Specific Committment to Mouse Genetics Focus Funding on Mouse Models To: Understand mechanism of action of disease genes and pathways Identify new drug targets Develop better animal models of human disease Work with partners to comprehensively phenotype mutants and share data $15M Support towards IMPC (Proportionate to $450M) Promote Animal Welfare => National Centre 3Rs An Inter(naetiodnaluc Centrae ftori Moousn,e G enegtiuics delines, r&d funding) Mary Lyon Centre MRC Harwell: MGU and MLC Overview Centre of Excellence in Mouse Genetics Since 1950 Impact of Radiation on Genomes, X Chromosome Inactivation, Imprinting, Systematic Mutagenesis
    [Show full text]
  • The Research Complex at Harwell (Rcah) Is a Multi-Disciplinary Laboratory for Cutting-Edge Research in Physical and Life Sciences
    THE RESEARCH COMPLEX AT HARWELL The Research Complex at Harwell (RCaH) is a multi-disciplinary laboratory for cutting-edge research in physical and life sciences. t £26.4 million, the RCaH (NERC), and STFC. STFC is the largest represents a significant stakeholder and the MRC manages the A Government investment in Complex. science and provides laboratory space for 150 people. LOCATION, LOCATION, LOCATION The RCaH is addressing a number The RCaH is based at STFC’s Rutherford of important and challenging areas Appleton Laboratory (RAL) at the including: Harwell Science and Innovation Campus in Oxfordshire. CONTACT • Advanced imaging in biology, Research Complex at Harwell engineering and materials science Its location is an important asset Rutherford Appleton Laboratory, Protein structure and function as the campus allows researchers to Didcot, • OX11 0FA • Drug development and delivery benefit from the proximity of a number • Chemical processing of facilities also on the Campus, For press and communication • Surface and nanoscience including the: enquiries please contact: • Energy research Jude Eades • ISIS neutron source MRC Publications Manager and Regional STAKEHOLDERS Diamond Light Source Communications Manager (Oxford & West) • RCaH has six stakeholders - • Central Laser Facility T: +44 (0)1235 841291 Biotechnology and Biological Sciences • Membrane Protein Laboratory Research Council (BBSRC), Diamond • MRC Mammalian Genetics Unit and For all other enquiries please contact: Light Source (DLS), Engineering and Mary Lyon Centre E: [email protected] Physical Sciences Research Council T: +44 (0)1235 567700 (EPSRC), Medical Resarch Council (MRC), This range of state-of-the-art facilities Natural Environment Research Council and expertise attracts researchers from different disciplines, encourages inter-disciplinary research, produces a dynamic working environment and increases the chances of scientific advances.
    [Show full text]
  • CLF Annual Report 2018-19.Pdf
    Central LaserLaser Facility Facility Annual ReportReport 20182018–2019 - 2019 A summary of this year’s experiments, papers and events. Central Laser Facility Science & Technology Facilities Council Rutherford Appleton Laboratory Harwell Campus Didcot, Oxfordshire OX11 0QX T: +44 (0)1235 445603 E: [email protected] W: www.clf.stfc.ac.uk Front cover design: Helen Towrie ISBN: 978-0-9574402-7-2 The production team for this Annual Report was as follows: Editor: Raoul Trines Production: Tracey Burge, Lizzie Henderson and Raoul Trines Section Editors: David Carroll, Richard Chapman, Ian Clark, Dave Clarke, Rob Clarke, James Green, Chris Hooker, Ian Musgrave, David Neely, Rajeev Pattathil, Jonathan Phillips, Dan Symes, Martin Tolley, Raoul Trines, Christopher Tynan, Adam Wyatt This report is available on the CLF website at www.clf.stfc.ac.uk Design, layout and production: UKRI Creative Services (JRS) Thanks to all of the above for their contribution towards producing this report and, of course, to all of the authors for their submissions. Contents Foreword 4 Overview of the Central Laser Facility 6 Industry Engagement and Innovation 10 Communication and Outreach Activities within the CLF 12 High Energy Density & High Intensity Physics 16 Laser Science & Development 27 Theory & Computation 37 Plasma Diagnostics 38 Ultrafast & XUV Science 41 Imaging & Dynamics for Physical & Life Sciences 43 Appendices 57 Operational Statistics 57 Publications 65 Panel Membership and CLF Structure 74 Central Laser Facility Annual Report 2018–2019 3 Foreword John Collier Director, Central Laser Facility, STFC Rutherford Appleton Laboratory, Harwell Campus, Didcot, UK Email address: [email protected] Website: www.clf.stfc.ac.uk This annual report for the Central Laser Facility (CLF) at the STFC Rutherford Appleton Laboratory provides highlights of scientific and technical research that has been carried out by users of the Facility and its staff over the financial year 2018-19.
    [Show full text]
  • Brief Genetics Report Deletion of Nicotinamide Nucleotide Transhydrogenase a New Quantitive Trait Locus Accounting for Glucose Intolerance in C57BL/6J Mice Helen C
    Brief Genetics Report Deletion of Nicotinamide Nucleotide Transhydrogenase A New Quantitive Trait Locus Accounting for Glucose Intolerance in C57BL/6J Mice Helen C. Freeman,1,2 Alison Hugill,1 Neil T. Dear,1 Frances M. Ashcroft,2 and Roger D. Cox1 The C57BL/6J mouse displays glucose intolerance and as a strong candidate gene (5). In C57BL/6J mice de- reduced insulin secretion. The genetic locus underlying scended from the colony established at The Jackson this phenotype was mapped to nicotinamide nucleotide Laboratory, we found that a spontaneous in-frame five- transhydrogenase (Nnt) on mouse chromosome 13, a nu- exon deletion in Nnt, also recently reported by Huang et clear-encoded mitochondrial protein involved in ␤-cell mi- al. (6), was linked to glucose intolerance and reduced tochondrial metabolism. C57BL/6J mice have a naturally insulin secretion. Although linkage analysis studies of occurring in-frame five-exon deletion in Nnt that removes complex traits cannot establish proof of QTLs identity at exons 7–11. This results in a complete absence of Nnt the molecular level, the genetic studies of defective Nnt in protein in these mice. We show that transgenic expression of the entire Nnt gene in C57BL/6J mice rescues their C57BL/6J mice strongly suggest a functional linkage be- impaired insulin secretion and glucose-intolerant pheno- tween this gene and the observed phenotype (7). Here, we type. This study provides direct evidence that Nnt defi- report transgenic rescue experiments demonstrating that ciency results in defective insulin secretion and defective Nnt is a QTL for glucose intolerance and im- inappropriate glucose homeostasis in male C57BL/6J mice.
    [Show full text]